@article{f2a388c66af4449c8c54f27da61c7502,
title = "Phase III randomized study of radiation and temozolomide versus radiation and nitrosourea therapy for anaplastic astrocytoma: results of NRG Oncology RTOG 9813",
author = "Susan Chang and Peixin Zhang and Cairncross, \{J. Gregory\} and Gilbert, \{Mark R.\} and Bahary, \{Jean Paul\} and Dolinskas, \{Carol A.\} and Arnab Chakravarti and Aldape, \{Kenneth D.\} and Bell, \{Erica H.\} and David Schiff and Kurt Jaeckle and Brown, \{Paul D.\} and Barger, \{Geoffrey R.\} and Maria Werner-Wasik and Helen Shih and David Brachman and Marta Penas-Prado and Robins, \{H. Ian\} and Karl Belanger and Christopher Schultz and Grant Hunter and Minesh Mehta",
note = "Background: The primary objective of this study was to compare the overall survival (OS) of patients with anaplastic astrocytoma (AA) treated with radiotherapy (RT) and either temozolomide (TMZ) or a nitrosourea (NU). Secondary endpoints were time to tumor progression (TTP), toxicity, and the effect of IDH1 mutation status on clinical outcome.",
year = "2016",
month = dec,
day = "18",
doi = "10.1093/neuonc/now236",
language = "American English",
volume = "19",
journal = "Neuro-oncology",
}